Stifel Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Sell |
13,040
-2,250
| -15% | -$19K | ﹤0.01% | 3354 |
|
|
2025
Q1 | $122K | Buy |
15,290
+600
| +4% | +$4.77K | ﹤0.01% | 3270 |
|
|
2024
Q4 | $143K | Buy |
14,690
+4,110
| +39% | +$39.9K | ﹤0.01% | 3215 |
|
|
2024
Q3 | $119K | Sell |
10,580
-1,620
| -13% | -$18.2K | ﹤0.01% | 3219 |
|
|
2024
Q2 | $127K | Hold |
12,200
| – | – | ﹤0.01% | 3178 |
|
|
2024
Q1 | $139K | Buy |
+12,200
| New | +$139K | ﹤0.01% | 3146 |
|
|
2023
Q4 | – | Sell |
-16,550
| Closed | -$168K | – | 3367 |
|
|
2023
Q3 | $168K | Sell |
16,550
-1,825
| -10% | -$18.6K | ﹤0.01% | 3031 |
|
|
2023
Q2 | $223K | Sell |
18,375
-6,664
| -27% | -$80.8K | ﹤0.01% | 2986 |
|
|
2023
Q1 | $308K | Buy |
25,039
+1,102
| +5% | +$13.6K | ﹤0.01% | 2795 |
|
|
2022
Q4 | $303K | Buy |
+23,937
| New | +$303K | ﹤0.01% | 2763 |
|
|
2022
Q2 | – | Sell |
-28,561
| Closed | -$429K | – | 3381 |
|
|
2022
Q1 | $429K | Buy |
+28,561
| New | +$429K | ﹤0.01% | 2659 |
|